Text messaging: Clinical Trials

2 trials of Text messaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Text messaging: new trials by email Literature Review of Text messaging trials Research Report on Text messaging

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Text Messaging Program for Smokers in Primary Care
Mailed nicotine replacement therapy, Text messaging, Brief advice - Smoking Cessation
Phase 4CompletedMassachusetts General Hospital1532017-11-062020-02-07
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
Text Messaging, Adherence Counseling, Daily Oral PrEP - HIV Prevention
Phase 4CompletedUniversity of California, Los Angeles1362016-05-012021-07-08

Conditions studied

Smoking Cessation (1)

Sponsors

Massachusetts General Hospital (1)  ·  University of California, Los Angeles (1)

Countries

United States (2)

Top investigators

Gina R Kruse, MD (1)  ·  Raphael Landovitz, MD (1)  ·  Sheldon Morris, MD (1)

Results publications

PMID 30923022, PMID 32198520, PMID 34851726, PMID 38822300

NIH funding

K23DA038717 (1)